Exploration of the tunability of BRD4 degradation by DCAF16 trans-labelling covalent glues
Authors:
Open Access
- 24 September 2024
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 279, 116904
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- PROTAC technology: From drug development to probe technology for target deconvolutionEuropean Journal of Medicinal Chemistry, 2024
- CRISPR Screen Reveals BRD2/4 Molecular Glue-like Degrader via Recruitment of DCAF16ACS Chemical Biology, 2023
- Molecular Glues: The Adhesive Connecting Targeted Protein Degradation to the ClinicBiochemistry, 2022
- Molecular Glues for Targeted Protein Degradation: From Serendipity to Rational DiscoveryJournal of Medicinal Chemistry, 2021
- Targeted protein degradation: A promise for undruggable proteinsCell Chemical Biology, 2021
- Recent Advances in Selective and Irreversible Covalent Ligand Development and ValidationCell Chemical Biology, 2019
- CRISPR-Mediated Tagging of Endogenous Proteins with a Luminescent PeptideACS Chemical Biology, 2017
- Covalent Modifiers: A Chemical Perspective on the Reactivity of α,β-Unsaturated Carbonyls with Thiols via Hetero-Michael Addition ReactionsJournal of Medicinal Chemistry, 2016
- A Bead‐Based Proximity Assay for BRD4 Ligand DiscoveryCurrent Protocols in Chemical Biology, 2015
- Covalent inhibition of SUMO and ubiquitin-specific cysteine proteases by an in situ thiol–alkyne additionBioorganic & Medicinal Chemistry, 2013